OncoMyx Therapeutics Company
OncoMyx Therapeutics develops oncolytic immunotherapies to orchestrate an immune response and treat cancer.
Technology:
Immunotherapy
Industry:
PharmTech
Headquarters:
Tempe, Arizona, United States
Founded Date:
2018
Employees Number:
1-10
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Register and Claim Ownership